Cargando…

Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2

CONTEXT: Type 2 diabetes mellitus (T2DM) in young adults is increasing in India. Data on the prevalence of cardiovascular (CV) risk factors and complications associated with young-onset T2DM (YOD) at the time of diagnosis of diabetes are limited. This data can aid in aggressive diabetes management,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosale, Bhavana, Sosale, Aravind R., Mohan, Anjana R., Kumar, Prassanna M., Saboo, Banshi, Kandula, Sai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743371/
https://www.ncbi.nlm.nih.gov/pubmed/26904479
http://dx.doi.org/10.4103/2230-8210.172277
_version_ 1782414353709924352
author Sosale, Bhavana
Sosale, Aravind R.
Mohan, Anjana R.
Kumar, Prassanna M.
Saboo, Banshi
Kandula, Sai
author_facet Sosale, Bhavana
Sosale, Aravind R.
Mohan, Anjana R.
Kumar, Prassanna M.
Saboo, Banshi
Kandula, Sai
author_sort Sosale, Bhavana
collection PubMed
description CONTEXT: Type 2 diabetes mellitus (T2DM) in young adults is increasing in India. Data on the prevalence of cardiovascular (CV) risk factors and complications associated with young-onset T2DM (YOD) at the time of diagnosis of diabetes are limited. This data can aid in aggressive diabetes management, CV risk reduction, and prevention of complications. AIM: To determine the prevalence of CV risk factors, micro and macrovascular complications in patients with newly diagnosed YOD. To assess the percentage of patients who require statin therapy based on current American Diabetes Association (ADA) guidelines. SETTINGS AND DESIGN: This was a retrospective cross-sectional study of 1500 patients with newly detected YOD across seven centers from 2013 to 2015. DESIGNS AND METHODS: Patients were evaluated for complications of diabetes and CV risk factors such as body mass index (BMI), hypertension, dyslipidemia, and smoking. STATISTICAL ANALYSIS: Measurements have been presented as mean ± standard deviation; results on categorical measurements have been presented in percentages. RESULTS: The mean age, glycated hemoglobin and BMI were 34.7 ± 4.2 years, 9.9 ± 2.4%, and 26.8 ± 4.7 kg/m(2). Hypertension, dyslipidemia, BMI >23 kg/m(2), and smoking were presented in 27.6%, 62.4%, 84.2%, and 24%. Diabetic retinopathy, neuropathy, and nephropathy were seen in 5.1%, 13.2%, and 0.9%. Ischemic heart disease, peripheral vascular disease, and stroke were presented in 0.7%, 2%, and 0.1%. As per current guidelines, 95.33% needed statin therapy. CONCLUSION: This study demonstrates that patients with YOD have micro and macrovascular complications at diagnosis. Nearly, every patient required a statin to reduce CV risk. This highlights the importance of screening patients with YOD for CV risk factors and complications of diabetes at the time of diagnosis.
format Online
Article
Text
id pubmed-4743371
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-47433712016-02-22 Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2 Sosale, Bhavana Sosale, Aravind R. Mohan, Anjana R. Kumar, Prassanna M. Saboo, Banshi Kandula, Sai Indian J Endocrinol Metab Original Article CONTEXT: Type 2 diabetes mellitus (T2DM) in young adults is increasing in India. Data on the prevalence of cardiovascular (CV) risk factors and complications associated with young-onset T2DM (YOD) at the time of diagnosis of diabetes are limited. This data can aid in aggressive diabetes management, CV risk reduction, and prevention of complications. AIM: To determine the prevalence of CV risk factors, micro and macrovascular complications in patients with newly diagnosed YOD. To assess the percentage of patients who require statin therapy based on current American Diabetes Association (ADA) guidelines. SETTINGS AND DESIGN: This was a retrospective cross-sectional study of 1500 patients with newly detected YOD across seven centers from 2013 to 2015. DESIGNS AND METHODS: Patients were evaluated for complications of diabetes and CV risk factors such as body mass index (BMI), hypertension, dyslipidemia, and smoking. STATISTICAL ANALYSIS: Measurements have been presented as mean ± standard deviation; results on categorical measurements have been presented in percentages. RESULTS: The mean age, glycated hemoglobin and BMI were 34.7 ± 4.2 years, 9.9 ± 2.4%, and 26.8 ± 4.7 kg/m(2). Hypertension, dyslipidemia, BMI >23 kg/m(2), and smoking were presented in 27.6%, 62.4%, 84.2%, and 24%. Diabetic retinopathy, neuropathy, and nephropathy were seen in 5.1%, 13.2%, and 0.9%. Ischemic heart disease, peripheral vascular disease, and stroke were presented in 0.7%, 2%, and 0.1%. As per current guidelines, 95.33% needed statin therapy. CONCLUSION: This study demonstrates that patients with YOD have micro and macrovascular complications at diagnosis. Nearly, every patient required a statin to reduce CV risk. This highlights the importance of screening patients with YOD for CV risk factors and complications of diabetes at the time of diagnosis. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4743371/ /pubmed/26904479 http://dx.doi.org/10.4103/2230-8210.172277 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sosale, Bhavana
Sosale, Aravind R.
Mohan, Anjana R.
Kumar, Prassanna M.
Saboo, Banshi
Kandula, Sai
Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
title Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
title_full Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
title_fullStr Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
title_full_unstemmed Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
title_short Cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in India: CINDI 2
title_sort cardiovascular risk factors, micro and macrovascular complications at diagnosis in patients with young onset type 2 diabetes in india: cindi 2
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743371/
https://www.ncbi.nlm.nih.gov/pubmed/26904479
http://dx.doi.org/10.4103/2230-8210.172277
work_keys_str_mv AT sosalebhavana cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2
AT sosalearavindr cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2
AT mohananjanar cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2
AT kumarprassannam cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2
AT saboobanshi cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2
AT kandulasai cardiovascularriskfactorsmicroandmacrovascularcomplicationsatdiagnosisinpatientswithyoungonsettype2diabetesinindiacindi2